Depending on whom you talk to, the CRISPR’d mushroom isn’t strictly defined as synthetic biology. Still, genetic technology exists on a continuum, and the regulatory conundrum the mushroom raises is relevant to any organism tweaked in a lab.
Over the past two years, policymakers had a fleeting chance to improve biotech laws—and they missed it. Now that we’re in the wild and unpredictable world of the Trump administration, the future of biotech regulation is a big fat question mark.
It could be that the agencies will just plug along under the radar and get some real work done. Or the changes and recommendations will languish, and we’ll be stuck with the 30-year-old coordinated framework. Or the Trump administration could wipe the regulations out completely….
Those last two choices—doing nothing or wiping out regulations altogether—would be huge mistakes. Either could allow for a flood of unregulated, and potentially risky, products. It would be much wiser to let the agencies continue the hard work of updating the laws for biological innovations, so we can have the confidence to pile a helping of CRISPR’d mushroom on our plate.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: The U.S. Regulations for Biotechnology Are Woefully Out of Date
For more background on the Genetic Literacy Project, read GLP on Wikipedia